Related Posts
FDA approves Cobenfy: A breakthrough Schizophrenia treatment after decades
The US FDA has approved Bristol Myers Squibb’s new oral medicine, Cobenfy, for treating schizophrenia in adults. This approval introduces a novel pharmacological approach after […]
Infosys ‘Power’ programme offering freshers Rs 9 lakh salary; substantially higher than Rs 3-3.5 lakh entry-level fresher pay
Infosys has launched a ‘power programme’ in campus placements, offering packages up to Rs 9 lakh per annum. The initiative focuses on specialised skills like […]
Total pauses fresh investments in Adani group till air cleared
TotalEnergies has halted further investments in the Adani Group following bribery allegations against top officials. The French energy giant stated it wasn’t aware of the […]